Caligan Partners »

Avalo Therapeutics Ord shares owned by Caligan Partners

Quarter-by-quarter ownership of Avalo Therapeutics Ord (AVTX) shares owned by Caligan Partners from 13F filings

Historical chart of Caligan Partners investment in Avalo Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Avalo Therapeutics Ord held by Caligan Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avalo Therapeutics Ord by Caligan Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $11M 833k 12.71

More positions owned by Caligan Partners

Liquidia Corporation Com New (LQDA)
Abivax Sa Sponsored Ads (ABVX)
Mineralys Therapeutics (MLYS)
Agios Pharmaceuticals (AGIO)
Exelixis (EXEL)
Revolution Medicines (RVMD)
Adma Biologics (ADMA)
Evolus (EOLS)
Merus N V (MRUS)
Xenon Pharmaceuticals (XENE)
Anika Therapeutics (ANIK)
Avalo Therapeutics Com New (AVTX)
Tyra Biosciences (TYRA)
Inhibrx Biosciences (INBX)
Verrica Pharmaceuticals Com Shs (VRCA)

View all positions for Caligan Partners

Top funds holding Avalo Therapeutics Ord

BVF
OrbiMed Advisors
Nantahala Capital Management
Point72 Asset Management
Affinity Asset Advisors
Caligan Partners
Balyasny Asset Management
Silverarc Capital Management
Vanguard Group
RA Capital Management
Citadel Advisors
TCG Crossover Management
Commodore Capital
Velan Capital Investment Management
Adage Capital Partners GP

View all funds holding Avalo Therapeutics Ord